$25.0M
AlbionVC led the Series A round for the healthcare-as-a-service provider, with backing from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI.
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
238
Total raised
£3.1B
disclosed amounts
This month
£7.8M
raised so far
£2.2M
The pre-series A round was backed by The FSE Group through the South West Investment Fund.
"Difficulty taking tablets is a common problem in paediatrics but extends to adults experiencing swallow impairment, including those suffering from serious conditions such as stroke, dementia and some forms of cancer. Our liquid products are effective and stable at room temperature with a long shelf life, improving medication adherence, dosage accuracy and convenience for the NHS, patients, and caregivers. We are thrilled to receive this investment, which will help us make a significant impact on the global pharmaceutical landscape."
£7.0M
Molten Ventures led the Series A round with participation from Marathon Venture Capital to support team expansion and platform development.
"What impressed us most is the PolyModels Hub team’s blend of technical know-how and deep understanding of its customers’ real-world challenges. They’ve built a solution that delivers value in weeks, not years, and its rapid adoption by major pharma companies speaks volumes."
£1.5M
The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.
"This additional funding represents strong continued confidence in our technology platform and our progress towards commercialisation. The support from Archangels, Scottish Enterprise and BBB Investments is enabling us to advance our clinical and manufacturing capabilities as we work towards regulatory approval."
Archangels + 2 others
£500K
The bridging round was led by British Design Fund to support global growth for the medical device innovator.
"This investment reflects strong support for our mission to improve patient safety worldwide. We’re encouraged by the growing interest in DoubleCHEK and remain focused on expanding access to safer enteral technologies."